Validation of SPARCC MRI-RETIC e-tools for increasing scoring proficiency of MRI sacroiliac joint lesions in axial spondyloarthritis

Autor: Maksymowych W; Medicine, University of Alberta, Edmonton, Alberta, Canada WALTER.MAKSYMOWYCH@UALBERTA.CA.; CARE ARTHRITIS Limited, Edmonton, Alberta, Canada., Hadsbjerg AEFEF; Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark.; Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Østergaard M; Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark.; Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Micheroli R; Department of Rheumatology, University Hospital of Zurich, Zurich, Switzerland., Pedersen SJ; Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Copenhagen Center for Arthritis Research, Rigshospitalet, Copenhagen, Denmark., Ciurea A; Department of Rheumatology, University Hospital of Zurich, Zurich, Switzerland., Vladimirova N; Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark.; Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Nissen MS; Rheumatology, Geneva University Hospitals, Geneva, Switzerland., Bubova K; First Faculty of Medicine, Rheumatology, Charles University, Prague, Czech Republic., Wichuk S; Rheumatology, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada., de Hooge M; Ghent University Hospital, Ghent, Oost-Vlaanderen, Belgium.; Leiden University, Leiden, Netherlands., Mathew AJ; Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark.; Clinical Immunology and Rheumatology, Christian Medical College and Hospital Vellore, Vellore, India., Pintaric K; Radiology, UKC Ljubljana, Ljubljana, Slovenia., Gregová M; First Faculty of Medicine, Rheumatology, Charles University, Prague, Czech Republic., Snoj Z; Radiology, UKC Ljubljana, Ljubljana, Slovenia., Wetterslev M; Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark.; Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Gorican K; Radiology, Geneva University Hospitals, Geneva, Switzerland., Möller B; Rheumatology, Inselspital Universitatsspital Bern, Bern, Switzerland., Eshed I; Diagnostic Imaging, Sheba Medical Center, Tel Hashomer, Israel.; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Paschke J; CARE Arthritis, Edmonton, Alberta, Canada., Lambert RG; Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada.
Jazyk: angličtina
Zdroj: RMD open [RMD Open] 2024 Feb 13; Vol. 10 (1). Date of Electronic Publication: 2024 Feb 13.
DOI: 10.1136/rmdopen-2023-003923
Abstrakt: Background: The Spondyloarthritis Research Consortium of Canada (SPARCC) developers have created web-based calibration modules for the SPARCC MRI sacroiliac joint (SIJ) scoring methods. We aimed to test the impact of applying these e-modules on the feasibility and reliability of these methods.
Methods: The SPARCC-SIJ RETIC e-modules contain cases with baseline and follow-up scans and an online scoring interface. Visual real-time feedback regarding concordance/discordance of scoring with expert readers is provided by a colour-coding scheme. Reliability is assessed in real time by intraclass correlation coefficient (ICC), cases being scored until ICC targets are attained. Participating readers (n=17) from the EuroSpA Imaging project were randomised to one of two reader calibration strategies that each comprised three stages. Baseline and follow-up scans from 25 cases were scored after each stage was completed. Reliability was compared with a SPARCC developer, and the System Usability Scale (SUS) assessed feasibility.
Results: The reliability of readers for scoring bone marrow oedema was high after the first stage of calibration, and only minor improvement was noted following the use of the inflammation module. Greater enhancement of reader reliability was evident after the use of the structural module and was most consistently evident for the scoring of erosion (ICC status/change: stage 1 (0.42/0.20) to stage 3 (0.50/0.38)) and backfill (ICC status/change: stage 1 (0.51/0.19) to stage 3 (0.69/0.41)). The feasibility of both e-modules was evident by high SUS scores.
Conclusion: The SPARCC-SIJ RETIC e-modules are feasible, effective knowledge transfer tools, and their use is recommended before using the SPARCC methods for clinical research and tria.
Competing Interests: Competing interests: WM has received honoraria/consulting fees from AbbVie, BMS, Boehringer Ingelheim, Celgene, Eli Lilly, Galapagos, Janssen, Novartis, Pfizer and UCB Pharma; research grants from AbbVie, Pfizer and UCB Pharma; and educational grants from AbbVie, Janssen, Novartis and Pfizer. WM is the Chief Medical Officer for CARE ARTHRITIS. MØ has received research grants from AbbVie, BMS, Merck, Novartis and UCB and speaker and/or consultancy fees from AbbVie, BMS, Boehringer Ingelheim, Celgene, Eli Lilly, Galapagos, Gilead, Hospira, Janssen, MEDAC, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCB. RM received honoraria for lectures or presentations from AbbVie, Eli Lilly, Janssen, Gilead and Pfizer. BM received travel expenditures, honoraria for lectures or presentations from AbbVie, Janssen, Novartis and Pfizer. MJN has received honoraria for travel expenditures, lectures or presentations from AbbVie, Eli Lilly, Janssen, Novartis, Pfizer and UCB. MdH received honoraria for presentations from UCB. RM received honoraria for presentations from UCB.
(© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze: MEDLINE
Externí odkaz: